Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone

Keyphrases

• Type 2 Diabetes Mellitus (T2DM) 100%
• Pioglitazone 100%
• Sitagliptin 100%
• Fixed-dose Combination Therapy 100%
• Insulin Resistance 50%
• Insulin 50%
• Insulin Sensitivity 50%
• Insulin Secretion 50%
• Single Tablet 50%
• Thiazolidinediones 50%
• Novel Combinations 50%
• Antidiabetic Agents 50%
• Fixed-dose Combination 50%
• Dipeptidyl peptidase-4 (DPP-4) 50%
• Postprandial Insulin 50%
• Pancreatic β-cells 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Combination Therapy 100%
• Pioglitazone Plus Sitagliptin 100%
• Insulin Resistance 50%
• Tablet 50%
• Antidiabetic Agent 50%
• Thiazolidinedione 50%
• Pioglitazone 50%
• Dipeptidyl Peptidase IV Inhibitor 50%
• Sitagliptin 50%